Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Li, Jia Yi
Popovic, Natalija
and
Brundin, Patrik
2005.
The use of the R6 transgenic mouse models of Huntington’s disease in attempts to develop novel therapeutic strategies.
NeuroRX,
Vol. 2,
Issue. 3,
p.
447.
Berger, Zdenek
Ttofi, Evangelia K.
Michel, Claire H.
Pasco, Matthieu Y.
Tenant, Sean
Rubinsztein, David C.
and
O'Kane, Cahir J.
2005.
Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway.
Human Molecular Genetics,
Vol. 14,
Issue. 20,
p.
3003.
Berger, Zdenek
Davies, Janet E.
Luo, Shouqing
Pasco, Matthieu Y.
Majoul, Irina
O'Kane, Cahir J.
and
Rubinsztein, David C.
2006.
Deleterious and protective properties of an aggregate-prone protein with a polyalanine expansion.
Human Molecular Genetics,
Vol. 15,
Issue. 3,
p.
453.
Berger, Zdenek
Ravikumar, Brinda
Menzies, Fiona M.
Oroz, Lourdes Garcia
Underwood, Benjamin R.
Pangalos, Menelas N.
Schmitt, Ina
Wullner, Ullrich
Evert, Bernd O.
O'Kane, Cahir J.
and
Rubinsztein, David C.
2006.
Rapamycin alleviates toxicity of different aggregate-prone proteins.
Human Molecular Genetics,
Vol. 15,
Issue. 3,
p.
433.
Vonsattel, Jean Paul G.
2007.
Huntington disease models and human neuropathology: similarities and differences.
Acta Neuropathologica,
Vol. 115,
Issue. 1,
p.
55.
Boone, J
Kate, F J W Ten
Offerhaus, G J A
van Diest, P J
Rinkes, I H M Borel
and
van Hillegersberg, R
2008.
mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?.
Journal of Clinical Pathology,
Vol. 61,
Issue. 8,
p.
909.
Bulat, Natasa
and
Widmann, Christian
2009.
Caspase substrates and neurodegenerative diseases.
Brain Research Bulletin,
Vol. 80,
Issue. 4-5,
p.
251.
Myung, Sun Jung
Yoon, Jung-Hwan
Kim, Bo Hyun
Lee, Jeong-Hoon
Jung, Eun Uk
and
Lee, Hyo-Suk
2009.
Heat Shock Protein 90 Inhibitor Induces Apoptosis and Attenuates Activation of Hepatic Stellate Cells.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 330,
Issue. 1,
p.
276.
Han, Ina
You, YiMei
Kordower, Jeffrey H.
Brady, Scott T.
and
Morfini, Gerardo A.
2010.
Differential vulnerability of neurons in Huntington’s disease: the role of cell type‐specific features.
Journal of Neurochemistry,
Vol. 113,
Issue. 5,
p.
1073.
Peterson, Quinn P
Goode, David R
West, Diana C
Botham, Rachel C
and
Hergenrother, Paul J
2010.
Preparation of the caspase-3/7 substrate Ac-DEVD-pNA by solution-phase peptide synthesis.
Nature Protocols,
Vol. 5,
Issue. 2,
p.
294.
Escartin, Carole
and
Brouillet, Emmanuel
2010.
The Nrf2 pathway as a potential therapeutic target for Huntington disease.
Free Radical Biology and Medicine,
Vol. 49,
Issue. 2,
p.
144.
Nagashima, Shun
Fukuda, Toshifumi
Kubota, Yuka
Sugiura, Ayumu
Nakao, Mitsuyoshi
Inatome, Ryoko
and
Yanagi, Shigeru
2011.
CRMP5-associated GTPase (CRAG) Protein Protects Neuronal Cells against Cytotoxicity of Expanded Polyglutamine Protein Partially via c-Fos-dependent Activator Protein-1 Activation.
Journal of Biological Chemistry,
Vol. 286,
Issue. 39,
p.
33879.
Jellinger, Kurt A.
2011.
Youmans Neurological Surgery.
p.
871.
Zhang, Y.
Yu, W.
Lv, G.
Zhu, J.
Wang, W.
Ma, X.
and
Liu, X.
2011.
Comprehensive Biotechnology.
p.
99.
Zhang, Y.
Yu, W.
Lv, G.
Zhu, J.
Wang, W.
Ma, X.
and
Liu, X.
2011.
Comprehensive Biotechnology.
p.
673.
Wang, Yu
Steimle, Paul A.
Ren, Yixin
Ross, Christopher A.
Robinson, Douglas N.
Egelhoff, Thomas T.
Sesaki, Hiromi
Iijima, Miho
and
Parent, Carole A.
2011.
Dictyostelium huntingtin controls chemotaxis and cytokinesis through the regulation of myosin II phosphorylation.
Molecular Biology of the Cell,
Vol. 22,
Issue. 13,
p.
2270.
Soldati, Chiara
Bithell, Angela
Conforti, Paola
Cattaneo, Elena
and
Buckley, Noel J.
2011.
Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington’s disease.
Journal of Neurochemistry,
Vol. 116,
Issue. 3,
p.
415.
Walter, Martin A.
Benz, Matthias R.
Hildebrandt, Isabel J.
Laing, Rachel E.
Hartung, Verena
Damoiseaux, Robert D.
Bockisch, Andreas
Phelps, Michael E.
Czernin, Johannes
and
Weber, Wolfgang A.
2011.
Metabolic Imaging Allows Early Prediction of Response to Vandetanib.
Journal of Nuclear Medicine,
Vol. 52,
Issue. 2,
p.
231.
Vagner, Tatyana
Young, Deborah
and
Mouravlev, Alexandre
2012.
Nucleic Acid-Based Therapy Approaches for Huntington's Disease.
Neurology Research International,
Vol. 2012,
Issue. ,
p.
1.
Cochran, Elizabeth J.
2012.
Neuropathology.
p.
240.